ALLO
MODERATEAllogene Therapeutics, Inc.
CIK: 0001737287
Sell
(70% confidence)
Last activity: 2 weeks ago
Financial Metrics
As of Dec 31, 2021 (10-K)
Net Income -$257.00M
Insider Roster (6 total, 6 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Chang David D President and CEO | 0 | 1 | -$171K | 5,185,862 shares $9.33M |
| Roberts Zachary EVP of R&D | 0 | 2 | -$104K | 581,166 shares $1.03M |
| Parker Geoffrey M. CHIEF FINANCIAL OFFICER | 0 | 1 | -$42K | 1,252,795 shares $2.20M |
| Douglas Earl Martin SVP, General Counsel | 0 | 1 | -$40K | 564,948 shares $994K |
| Beneski Benjamin Machinas SVP, Chief Technical Officer | 0 | 2 | -$14K | 210,172 shares $364K |
| Yoshiyama Annie SVP, Finance | 0 | 1 | -$7K | 130,322 shares $224K |
Recent Transactions
SELL Chang David D (President and CEO)
95,269 shares @ $1.80
$171K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Roberts Zachary (EVP of R&D)
35,700 shares @ $1.77
$63K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Parker Geoffrey M. (CHIEF FINANCIAL OFFICER)
24,001 shares @ $1.76
$42K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Douglas Earl Martin (SVP, General Counsel)
22,900 shares @ $1.76
$40K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Beneski Benjamin Machinas (SVP, Chief Technical Officer)
7,549 shares @ $1.73
$13K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Yoshiyama Annie (SVP, Finance)
4,167 shares @ $1.72
$7K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Roberts Zachary (EVP of R&D)
26,269 shares @ $1.56
$41K
Jan 21, 2026
Conviction: |
View SEC Filing →
SELL Beneski Benjamin Machinas (SVP, Chief Technical Officer)
786 shares @ $1.22
$959
Nov 17, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.